Growth Metrics

Ocugen (OCGN) Cash from Operations Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 60.84%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 85.14%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -15.72%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 74.39%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 3.23%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 158.60%
10 Ocugen 452.01 Mn 452.01 Mn - -12.59%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -12.59%
Dec 31, 2025 -34.71%
Sep 30, 2025 -14.58%
Jun 30, 2025 -8.26%
Mar 31, 2025 -82.70%
Dec 31, 2024 8.30%
Sep 30, 2024 17.76%
Jun 30, 2024 47.30%
Mar 31, 2024 41.91%
Dec 31, 2023 33.18%
Sep 30, 2023 4.17%
Jun 30, 2023 -36.30%
Mar 31, 2023 -21.07%
Dec 31, 2022 -32.10%
Sep 30, 2022 -77.60%
Jun 30, 2022 36.71%
Mar 31, 2022 -185.18%
Dec 31, 2021 -198.95%
Sep 30, 2021 -203.54%
Jun 30, 2021 -606.22%
Mar 31, 2021 -12.74%
Dec 31, 2020 51.02%
Sep 30, 2020 -25.23%
Jun 30, 2020 8.23%
Mar 31, 2020 -75.69%
Dec 31, 2019 -213.84%
Sep 30, 2019 69.38%
Jun 30, 2019 35.47%
Mar 31, 2019 -181.17%
Dec 31, 2018 35.49%
Sep 30, 2018 -20.79%
Jun 30, 2018 7.39%
Mar 31, 2018 144.74%
Dec 31, 2017 26.71%
Sep 30, 2017 -4.91%
Jun 30, 2017 13.97%
Mar 31, 2017 6.33%
Dec 31, 2016 15.78%
Sep 30, 2016 20.68%
Jun 30, 2016 12.36%
Mar 31, 2016 9.76%
Dec 31, 2015 -49.57%
Sep 30, 2015 -146.23%
Jun 30, 2015 -37.09%
Mar 31, 2015 -73.12%